Analyses / ZS
Fast-growing cybersecurity name at 8.9x sales, GAAP operating loss, heavy insider selling, and a sharp day-on-day rebound from the mid-range of its 52-week band.
A free account reveals ZS's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Revenue growth of 27.5% (5-year: 37.9%) and a 76.8% gross margin point to a scalable subscription model. Shares are about 35% below the 304.80 52-week high, so a re-rating is possible if margins move toward breakeven. Today's +6.8% move on a 184.78 to 202.36 intraday range suggests sector demand (headlines cite AI security and peer moves at Palo Alto and Okta) is being priced in. If the 202.36 day high is cleared with follow-through, the rebound could extend toward the 210 base-case area. Beta of 0.94 is below market, which may limit the market-level drag in a broad pullback.
▼ Bear Case
Operating margin is -3.98% and net margin is -1.88%, so the company is not yet profitable on a GAAP basis. Price-to-sales of 8.9x and price-to-book of 9.4x leave little room for a slowdown in growth. Insider activity skews to selling: 76 sales against 15 purchases, with 143,310 shares sold versus 102,642 bought. Headlines show a fast-moving sector narrative, so the stock may be sensitive to rotation out of cybersecurity names. EV/EBITDA is negative at -256x, so cash-earnings valuation cannot anchor the price. Failure to hold 184.78 would weaken the rebound read.
Valuation
EXPENSIVE ON SALES — score 35/100
Sales multiples are high for a company with GAAP losses. Growth and gross margin partly offset this, but insider selling and missing earnings metrics limit confidence.
Technical Levels
Support · $184.78 (Intraday low (today)) · $185.19 (Previous close) · $114.63 (52-week low)
Resistance · $202.36 (Intraday high (today)) · $304.80 (52-week high)
Financial Health
Score 62/100. Liquidity ratios look adequate. Leverage data is missing, and GAAP profitability is negative, so balance sheet strength cannot be fully assessed from this payload.
Risk Flags
See ZS's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock ZS free →Recent News
- Zscaler Stock Faces AI Security Test After Commvault PartnershipYahoo
- Palo Alto Soars 7%, Okta Up 11% as DHS Chief Warns of “A Severe Cyber Threat”Yahoo
- Google Says Fully Autonomous AI Cyberattacks Are Likely Within 6 MonthsYahoo
- Can Rising Cyber Threats Accelerate Cloudflare's Security Growth?Yahoo
- Zscaler (ZS) Stock Still Looks Cheap On Its 46% Five Year SlumpYahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full ZS analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
ZS FAQ
Is ZS a buy right now?
Zscaler, Inc.'s current read is a Momentum rebound with unresolved profitability setup with low confidence over a 1-3 months horizon. Valuation: EXPENSIVE ON SALES. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is ZS overvalued?
EXPENSIVE ON SALES (valuation score 35/100). Sales multiples are high for a company with GAAP losses. Growth and gross margin partly offset this, but insider selling and missing earnings metrics limit confidence.
What are the risks of buying ZS?
Operating margin is -3.98% and net margin is -1.88%, so the company is not yet profitable on a GAAP basis. Price-to-sales of 8.9x and price-to-book of 9.4x leave little room for a slowdown in growth. Insider activity skews to selling: 76 sales against 15 purchases, with 143,310 shares sold versus 102,642 bought. Headlines show a fast-moving sector narrative, so the stock may be sensitive to rotation out of cybersecurity names. EV/EBITDA is negative at -256x, so cash-earnings valuation cannot anchor the price. Failure to hold 184.78 would weaken the rebound read.